Article
Genetic and Genomic Testing for Prostate Cancer: Beyond DNA Repair
1 May 2023
Abstract excerpt
Significant progress has been made in genetic and genomic testing for prostate cancer across the disease spectrum. Molecular profiling is increasingly relevant for routine clinical management, fueled in part by advancements in testing technology and integration of biomarkers into clinical trials. In metastatic prostate cancer, defects in DNA damage response genes are now established predictors of benefit to US...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
